Correct Answer: A. Fine needle aspiration cytology (FNAC) is not diagnostic
This question describes a thyroid malignancy with cervical lymph node involvement, and the histopathology image (though not visible here) most likely shows papillary thyroid carcinoma (PTC), the most common thyroid cancer in India. The correct statement is that FNAC is NOT diagnostic for PTC — this is a critical teaching point often missed by students. While FNAC is excellent for distinguishing benign from malignant thyroid nodules overall, it cannot reliably diagnose PTC because the cytological features (nuclear grooves, intranuclear pseudoinclusions, pale nuclei) overlap significantly with benign follicular lesions and follicular adenomas. FNAC is classified as "indeterminate" or "atypia of undetermined significance" in many PTC cases, requiring core needle biopsy or surgical excision for definitive diagnosis. In Indian practice, when PTC is suspected clinically (especially with lymph node involvement), thyroidectomy with histopathology remains the gold standard. FNAC sensitivity for PTC is only 65–75%, making it unreliable as a standalone diagnostic tool — hence the statement "FNAC is not diagnostic" is TRUE, and this is the FALSE statement option the question seeks.
Why the other options are wrong
B. Excellent prognosis is associated with this condition — This is TRUE and a hallmark of PTC. PTC has the best prognosis among thyroid malignancies, with 10-year survival rates >90% in India, even with lymph node metastases. The presence of cervical nodes does not significantly worsen prognosis in PTC (unlike anaplastic or medullary carcinoma), making this a correct statement about the condition. C. It spreads quickly via lymphatics — This is TRUE. PTC characteristically spreads early to cervical lymph nodes (central and lateral compartments) via lymphatic channels — this is so common that 20–50% of PTC patients present with nodal metastases. The patient's presentation with cervical node enlargement is classic for PTC's lymphatic spread pattern, making this a correct statement. D. Nuclear characteristics are used for the identification — This is TRUE and fundamental to PTC diagnosis. Histopathology relies on distinctive nuclear features: nuclear grooves, intranuclear pseudoinclusions, pale/empty nuclei, and irregular nuclear membranes. These are the gold standard for PTC identification on histology, making this a correct statement about diagnostic criteria.
High-Yield Facts
- FNAC sensitivity for PTC is only 65–75% — indeterminate results are common; core biopsy or thyroidectomy needed for confirmation
- PTC has >90% 10-year survival even with cervical node metastases; nodal involvement does not significantly alter prognosis
- PTC spreads to cervical nodes in 20–50% of cases — central and lateral compartment involvement is characteristic
- Nuclear grooves and intranuclear pseudoinclusions are pathognomonic on histology; FNAC cannot reliably detect these features
- Thyroidectomy with histopathology is gold standard for PTC diagnosis in Indian practice when clinical suspicion is high
Mnemonics
PTC Diagnosis: FNAC Trap FNAC Not Always Confirms = FNAC may be indeterminate in PTC; histology is definitive. Use when deciding whether FNAC alone is enough to diagnose PTC. PTC Prognosis: BEST Among Thyroid Cancers Better than medullary, Excellent vs anaplastic, Survival >90%, Treatable even with nodes. Helps remember why PTC with lymph node involvement still has excellent outcomes.
NBE Trap
NBE pairs "FNAC is diagnostic" with "excellent prognosis and lymphatic spread" to trap students who assume FNAC is always reliable for thyroid cancer diagnosis. The trap is conflating FNAC's utility in general thyroid nodule triage with its poor sensitivity specifically for PTC cytology.
Clinical Pearl
In Indian tertiary centers, when a young patient presents with a thyroid nodule + cervical lymphadenopathy, FNAC often returns "indeterminate" or "suspicious for malignancy" — this is NOT diagnostic and mandates thyroidectomy. Many students incorrectly assume FNAC "rules in" PTC; in reality, it only raises suspicion. Histology on the resected specimen is what confirms PTC and guides adjuvant radioiodine therapy decisions.
_Reference: Bailey & Love Ch. 39 (Thyroid Surgery); Robbins Ch. 24 (Endocrine Pathology)_